Population-based studies have shown that one in three children with cerebral palsy (CP) will have hip displacement. [1] [2] [3] [4] A direct relationship has been established between hip displacement, defined as a Reimer's migration percentage greater than 30% to 33%, and Gross Motor Function Classification System (GMFCS) levels. [1] [2] [3] [4] [5] Migration percentage is the percentage of the femoral head that sits outside the lateral margin of the acetabulum. 6 The GMFCS is a five-level ordinal scale that is used to classify a child's motor function based on self-initiated movement. 7, 8 The risk of hip displacement increases with each GMFCS level. Children whose motor function is classified in GMFCS level I have very low risk of hip displacement while those classified in level V have a 68% to 90% risk. [1] [2] [3] Hip displacement and dislocation can significantly impact function and quality of life in individuals with CP. Loss of sitting and walking tolerance, difficulty with dressing and bathing, reduced hip motion, pelvic obliquity, scoliosis, and pain have been reported with hip displacement and dislocations. 4, 9, 10 Penner et al. 11 found the most common cause of pain in children and young people with CP attending an outpatient clinic was hip displacement/dislocation and a recent study by Ramstad and Terjesen 12 reported increasing frequency in hip pain with migration percentage at or above 50%. In 2014, Jung et al. 13 reported a decrease in health-related quality of life with increasing migration percentage. The high morbidity associated with hip displacement necessitates that it be treated.
No clinical measures have been found to accurately identify hip displacement. 2, 14 Radiographs of the pelvis are required. Migration percentage has been accepted as the most valid and reliable method of monitoring hip displacement from a single anterior-posterior pelvis radiograph. 15 In studies of validity, a threshold for true change between successive radiographs has been defined as 8.3% to 10% when measured by the same rater, and 11% to 11.5% when measured by different raters. 16, 17 When the measurer is inexperienced, this value is increased. 18 Changes in migration percentage greater than 10% are therefore considered clinically important. 16, 17, 19 Other radiological measures, including acetabular index and centre-edge angle, have also been used but found to be less reliable indicators of hip displacement. 6, [19] [20] [21] Once hip displacement reaches a migration percentage greater than 40%, preventive or reconstructive orthopaedic surgery is often recommended. 22 , 23 Hagglund et al. 21 reported that hips with a migration percentage up to 40% may correct spontaneously but that no hips with a migration percentage greater than 42% returned to normal without orthopaedic surgery. All hips with a migration percentage over 60% are expected to progress to full dislocation. 19 The timing of orthopaedic surgeries, including optimal age and migration percentage, remains unclear in the existing literature. [24] [25] [26] With the high incidence and important consequences of hip displacement, parents, physicians, and therapists often seek treatments to prevent hip displacement from occurring or worsening. Established hip surveillance programmes begin monitoring for hip displacement at 1 to 2 years of age, allowing for early detection and treatment. 3, 5, 21, 22 When detected early, orthopaedic surgical interventions may not yet be indicated and treatment to prevent further progression is desired. The purpose of this systematic review was to identify and appraise the current evidence on interventions aimed at preventing or reducing the rate of hip displacement in children and young people with CP as measured by a change in a radiological measure.
METHOD Search strategy
The Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) statement 27 and American Academy of Cerebral Palsy and Developmental Medicine (AACPDM) Methodology to Develop Systematic Reviews of Treatment Interventions (Revision 1.2) 28, 29 were used to guide this review. A literature search was conducted in June 2015 of MEDLINE (from 1946), CINHAL (from 1982), Embase (from 1974), Cochrane Database of Systematic Reviews (from 1993; www.cochrane.org), Database of Reviews of Effectiveness (DARE), Physiotherapy Evidence Database (PEDro; www.pedro.fhs.usyd.edu.au), and OT Seeker (www.otseeker.com). Individual search strategies were used for each database; the search strategies were reviewed by multiple authors. A search strategy was developed for MEDLINE using key words for cerebral palsy, hip displacement, and radiological measures (see Table SI , online supporting information). Key terms were mapped to medical subject headings (MeSH) in MED-LINE and exploded to include subheadings and related terms whenever possible in all databases. No limits were placed on the study methodology and all languages were included in the initial search but only English language studies were included in the data extraction. Searches were supplemented by hand searching the reference lists of all included articles. Studies e-published ahead of print up until November 2015 were included; these studies were identified through scholarly alerts. No study authors were contacted to identify additional studies. Details of the protocol for this systematic review were specified in advance and were registered. 30 
Eligibility criteria
Three authors (SDM, KH, and MJ) each independently reviewed titles and abstracts for the articles yielded in the search. Where there was disagreement on eligibility, fulltext manuscripts were obtained. Studies were included if they: (1) involved participants aged 0 to 19 years with CP; 31 (2) reported effectiveness of an intervention aimed to prevent hip displacement; (3) included a radiological measure; and (4) were original, peer-reviewed literature published in English. Studies involving children with hip displacement due to congenital hip pathology or neuromuscular diseases of spinal or muscular origin were excluded as the underlying cause and mechanism of displacement differs. Additionally, studies reporting results of orthopaedic interventions were excluded as we were interested in interventions that could be used to delay or avoid orthopaedic interventions. Abstracts from scientific meetings were not included in this review. Using standardized forms based on the AACPDM methodology, both reviewers extracted data including the study practice setting, participant description and number, intervention, control state, outcomes, and adverse events. Consensus on content of tables and ratings was achieved through discussion and a third reviewer, where required. Each paper was classified according to the Oxford Centre for Evidence-Based Medicine (OCEBM) 2011 Levels of Evidence. [32] [33] [34] The methodological quality of studies classified as levels I to III was independently assessed by two reviewers using the AACPDM quality conduct questions. 29 Annual rate of change in migration percentage was calculated for included articles where possible.
Data extraction and quality appraisal

RESULTS
Search yield
The initial search yielded 1045 articles (Fig. S1 , online supporting information). After removing duplicates, the titles and abstracts of 659 articles were retrieved and reviewed. Using the inclusion and exclusion criteria, 595 articles were eliminated and 64 full-text articles were retrieved for further review. Four non-English language publications that addressed the study question were excluded. After full-text What this paper adds
• High-quality evidence on prevention of hip displacement is lacking.
• No recommendations can be made for preventing hip displacement in children with cerebral palsy because of poor-quality evidence.
• High-quality, prospective, longitudinal studies investigating the impact of interventions on hip displacement are required.
Review 1131 review, 23 papers remained. A search of the reference lists of these articles and key articles on hip displacement identified one additional article (Greene et al. 58 ). One additional paper (Macias-Merlo et al. 59 ) and a systematic review (Blake et al. 60 ) were e-published ahead of print (October 2015 and November 2015) and were identified through scholarly alerts; these were retrieved and included in the review. After further review, the systematic reviews that met the inclusion criteria (Novak et al., 57 Blake et al. 60 ) were eliminated because the relevant studies within these reviews were retrieved during our initial search or did not provide any additional information.
In total, 24 articles were included in our systematic review, encompassing studies that investigated the use of BoNT-A, [35] [36] [37] [38] BoNT-A and bracing, 39, 40 CAM therapies, 41 ITB, 42 obturator nerve block, 43 positioning, [44] [45] [46] [47] [48] [49] [50] 59 and SDR. [51] [52] [53] [54] [55] [56] 58 Table SII (online supporting information) summarizes the study design, level of evidence and quality score, participant characteristics, intervention, and length of followup of the included studies. Conduct scores are provided in Table SIII (online supporting information). Although the quality of studies at levels I to III was evaluated, a formal risk assessment for bias was not done as per PRISMA guidelines owing to the low level of evidence of the available studies.
Study design and quality
The included studies were published between 1991 and 2015. All studies used a group design. Most studies were graded as level 3 (n=6) or level 4 (n=15) evidence according to the OCEBM scale. Level of evidence was primarily due to study design. The most common study design was cohort with no controls (n=14). Six studies used a concurrent control and one used a historical control. Only one randomized controlled trial (RCT) and one long-term follow-up study of the same RCT was found. 39, 40 Twelve studies were done prospectively while 12 were retrospective.
Participant demographic profile
Participant demographics are listed in Table SII and were highly variable across age, motor function, and migration percentage at enrolment. CP was poorly defined in most studies. Participants in all studies related to BoNT-A, ITB, obturator nerve block, and SDR were described as having a spastic motor type while participants of all motor types were more likely to be included in articles related to positioning. GMFCS levels were reported for participants in two-thirds of all studies, including all those published after 2006 except one case report (Picciolini et al. 48 ).
Outcome measures
The most common measure of hip displacement used in the studies was migration percentage. It was reported in 22 out of 24 studies and was, therefore, used as our primary outcome measure. In addition, Hodgkinson et al. 55 reported using lateral femoral head extrusion but did not describe their method of measurement or reference migration percentage. One paper (Hicdonmez et al. 54 ) used centre-edge angle as their primary measure of hip displacement. Secondary radiological outcome measures included acetabular index, femoral neck shaft angle, femoral anteversion, and centre-edge angle. The Melbourne Cerebral Palsy Hip Classification Scale was used in two studies to describe hip morphology. Progression to surgery, including age at surgical intervention and surgery type/complexity, was used in five studies. All of these outcomes were within the International Classification of Functioning, Disability and Health (ICF) construct of body functions and structure. 61 Additional outcomes reported at the level of body function and structure included muscle tone, range of motion, Cobb angle (scoliosis), sleep, and bone mineral density. Very few studies reported the impact of the study intervention on activity and participation. No studies in this review discussed the relationship between migration percentage and outcomes representing the ICF components of activity and participation.
Study outcomes
Table SIV (online supporting information) summarizes the outcomes for each study; only outcomes related to hip displacement were included. Owing to the low level of evidence, all studies except level V studies were included in this summary of results. To facilitate comparison of study results, the mean annual change in migration percentage was calculated, whenever possible, from data provided and is listed in Table I . Migration percentage values are reported such that increases in migration percentage, indicating worsening hip displacement, are positive numbers while deceases in migration percentage, or improvements in hip displacement, are negative.
BoNT-A with or without bracing
Four studies investigated the impact of BoNT-A on hip displacement. [35] [36] [37] [38] Only one study was graded as level 3 evidence; 38 the remaining studies were graded as level 4. Participant characteristics and injection protocols varied considerably. Both single-and repeat-injection protocols were studied. Two studies 35, 37 used BoNT-A in the form of Dysport while the other two 36, 38 used Botox. The authors of all four studies suggested that BoNT-A has or may have an impact on hip displacement in some children with CP. In the only level 3 study (moderate quality), Yang et al. 38 found a statistically significant difference in the rate of displacement between the BoNT-A group (À0.7%/y, standard deviation [SD] 6.5%/y) and the nonintervention group (+4.4%/y, SD 11.3%/y). Annual mean changes in migration percentage were calculated for the remaining studies as +0.5% (Jung et al. 35 ), +0.4% (Pidcock et al. 36 ), and À8.2% per year (Placzek et al. 37 ). In addition, a 3-year-long RCT 39 and a follow-up study of a subset of the participants at a mean of 10 years 10 months (Willoughby et al. 40 ) have been published on the influence of BoNT-A (Botox) and bracing with a Sitting Walking And Standing Hip orthosis (SWASH). The SWASH allows for maximum abduction during hip flexion and neutral hip abduction during hip extension and weight-bearing. These two studies were graded as level 2 and 3 evidence with quality ratings of strong and moderate, respectively. Initial results of the RCT by Graham et al. 39 found that migration percentage in the intervention group increased less (+2.6% per year) than the control (+5.7% per year), and fewer children in the intervention group progressed to surgery (11/47) compared with the comparison group (22/44) . Despite these findings, the authors did not recommend the intervention owing to continued progressive displacement. The follow-up study found that the long-term hip morphology, migration percentage, and age at which preventative or reconstructive surgery was indicated were not affected by the study intervention.
ITB
One level 4 study investigated the effect of ITB infusion on hip displacement 1 year after pump placement. 42 Participants were not restricted to paediatric patients (4-31y 5mo), the study included those at all GMFCS levels, and it did not exclude those having previously undergone orthopaedic surgery for hip displacement. The annual rate of change in migration percentage was +1.3% (SD 11.7%). The authors reported this was a positive result compared with the rate reported in the literature for the natural history of hip displacement (+5% per year [Vidal et al. 62 ]).
Obturator nerve block
One level 3 study (Park et al. 43 ) investigated the effect of obturator nerve block on hip displacement. Only children in GMFCS levels III to V and having an initial migration percentage of 20% to 60% were included and compared with an appropriately concurrent control group. The annual change in migration percentage was +1.09% (SD 7.63%). The authors suggest that this treatment may be effective in controlling hip displacement in the short term.
SDR
The impact of SDR on hip displacement was reported in seven studies, all graded as level 4 or 5 evidence. [51] [52] [53] [54] [55] [56] 58 The percentage of afferent rootlets cut varied considerably within and between studies (5%-85%).
Four studies concluded SDR may have a positive effect on hip displacement. [52] [53] [54] 56 Annual change in migration percentage could only be calculated for Floeter et al. 52 at À1.7% per year. Three of these studies reported stability rates, whereby the migration percentage was either unchanged or improved, in 82% to 93% of hips; mean length of follow-up was 4 years or less. 53, 54, 56 Chan et al. 51 concluded that SDR had a neutral effect when 90% of those with preoperative hip subluxation continued to do so postoperatively, and 88% of those with typically developing hips preoperatively remained normal. Similarly, Hodgkinson et al. 55 reported no evolution of hip migration but that SDR did not have a preventative effect. A small case series reported rapid progression in five non-ambulatory patients. 58 
CAM
One article addressed the effect of CAM therapies on long-term surgical requirements and radiological outcomes for individuals with CP in GMFCS levels II to V. 41 This was a level 3 study of moderate quality. Participants, who had a migration percentage greater than 40% in one or both hips and less than 40°of abduction in one or both hips, had been recommended hip surgery but declined. Multiple CAM approaches (see Table SII ) were identified but the intensity, frequency, and quality of CAM therapies was not available. As all non-ambulant children in the study progressed to hip surgery at last follow-up, the authors reported that CAM therapies did not appear to have a clinically significant impact on hip development in their study participants.
Positioning
Eight articles, published between 2002 and 2015, addressed the effect of positioning on hip displacement. [44] [45] [46] [47] [48] [49] [50] 59 Two 47,59 were graded as level 3, five [44] [45] [46] 49, 50 as level 4, and one 48 as level 5. Positioning devices included standing devices, custom seating systems, 24 hours' postural management, and sleep systems. In six studies, the hips were positioned in abduction; none of the articles commented on positioning the hip in flexion/extension or internal/external rotation. Daily use and duration of intervention varied considerably.
Results of the two low-quality level 3 studies suggested there may be a positive impact on hip displacement when children in GMFCS levels III to V stand with hips in abduction for more than an hour. 47, 59 The remaining level 4 studies found either a small or no measurable effect. Only Dal en et al. 44 reported a negative association between standing time (hips in neutral position) and hip displacement in children with spasticity.
Adverse events
Only four articles reported adverse events (Table II) . 35, 39, 42, 55 Krach et al. 42 reported the most adverse events in their study of ITB (29 of 33 participants experienced at least one adverse event) while Graham et al. 39 had the most 'major' adverse events (12) during their RCT of BoNT-A and bracing.
DISCUSSION
The aim of treating hip displacement in children and young people with CP is to achieve a stable, mobile, and pain-free hip into adulthood. 22 Achieving this with an intervention that is less invasive than orthopaedic surgery or that offers an additional functional benefit to the child would be desirable. While the ideal age to perform orthopaedic hip interventions remains unclear, [24] [25] [26] older age at time of reconstructive surgery is associated with a lower rate of surgical revision; 63 therefore, non-operative interventions that slow the rate of hip displacement and delay the need for orthopaedic surgery may also be considered successful. This systematic review found that tone management strategies, positioning interventions, and complementary and alternative medicines have been investigated to explore their ability to slow or prevent hip displacement in children and young people with CP. BoNT-A, botulinum neurotoxin A.
Interventions targeting spasticity
The cause of hip displacement in children with CP is not fully understood. The hip joint in children with CP is normal at birth. Increased muscle tone (primarily spasticity), and contractures of the adductors and medial hamstrings have long been felt to be the underlying cause of hip displacement. 64, 65 Abnormal muscle forces and muscle imbalance around the hip are believed to shift the mechanical axis of the hip. This has led to trialling interventions that decrease spasticity, including SDR, BoNT-A, ITB, and obturator nerve block to control, reduce, or prevent progressive hip displacement.
The effect of SDR on hip displacement was the most frequently studied tone management intervention. However, all seven studies were graded as level 4 or 5 evidence. The lack of rigorously designed studies limits the information gained on the effect of SDR on hip displacement.
Only one level 3 study investigated the effect of BoNT-A on hip displacement, with progression of displacement lower in the intervention group (À0.7%/y, SD 6.5%/y) than in the control group (+4.4%/y, SD 11.3%/y). 38 With the addition of a SWASH brace, Graham et al. 39 (level 2 evidence) also found that the mean annual change in migration percentage was less (+2.6% per year) than the control (+5.7% per year). While these studies suggest a clinical effect may exist from the use of BoNT-A, the treatment effects were small and the clinical relevance remains unclear. In the only study to complete long-term follow-up, Willoughby et al. 40 reported no difference in mean age at time of preventive or reconstructive surgery or in hip morphology between the intervention and control groups on the basis of their centre's surgical indications. On the basis of the available evidence, no recommendations for the use of BoNT-A to slow or prevent hip displacement can be made.
Similarly, one study looking at obturator nerve block (level 3) as an alternative for BoNT-A found no clinically significant differences in the intervention and control groups at last follow-up. 43 Finally, one level 4 study investigated the impact of ITB infusion on hip displacement, but no conclusions can be made based on this low-level study. 42 Overall, there is insufficient evidence to provide recommendations on tone management strategies to slow or prevent hip displacement in children and young people with CP. Although several authors reported that the intervention studied had a statistically significant, positive impact on hip displacement, the level of evidence is low and the lack of long-term follow-up studies limits our ability to determine whether the effects were clinically meaningful. The heterogeneity in patient populations (including GMFCS levels, age, and intitial hip status), and differences in reporting outcomes also prevent comparison between the different strategies.
Interventions targeting femoral geometry
With the association between hip displacement and GMFCS levels now evident, the contribution of motor function to hip development has become increasingly apparent. Robin et al. 66 demonstrated that changes in the proximal femur, specifically persistent femoral anteversion and increased femoral neck shaft angle, are related to a child's functional ambulation as described by GMFCS levels. As such, interventions that might affect the proximal femoral geometry through optimal positioning and/or weight-bearing have been studied.
Eight studies investigated the role of positioning in slowing or preventing hip displacement; [44] [45] [46] [47] [48] [49] [50] 59 only two of these studies were graded as level 3 evidence. 47, 59 Both of these studies reported a positive impact on hip displacement in children in GMFCS levels III to V when standing in hip abduction for greater than 1 hour per day. However, these studies had small samples and short follow-up (1-4y), limiting our ability to make firm conclusions. Studies that follow participants until skeletal maturity are required to determine whether there is a clinically important impact on hip displacement. Additionally, the amount of time in the device, the influence of weight-bearing, and the optimal age at which to introduce the equipment require further investigation.
Finally, one study explored the use of CAMS on hip displacement. 41 Although there seemed to be no clinically significant benefit from the CAM therapies, no conclusions can be made owing to the variability of therapies offered and the small sample size.
Interpretation of results
In an effort to compare interventions, the annual rate of change in migration percentage was calculated. We were able to calculate an annual rate of change for 13 of the 22 studies graded levels 2 to 4; values ranged from À8.2% to +3.2% per year (see Table I ). As such, changes in migration percentage were within the range of measurement error for this outcome measure, further limiting the interpretation of the results.
Most these studies did not have a comparative control group representing the natural history of progressive hip displacement in the pertinent patient population. In cohort studies or case series that lack an appropriate control group, no definitive conclusions can be made about the impact of a given intervention, even if reporting a positive or neutral outcome. Neutral effects (i.e. lack of migration percentage progression) are potentially beneficial given prevention goals, but are only meaningful when paired with a comparative control. Additionally, the rate of increase in migration percentage in children with CP when left untreated is not clearly defined in the literature, further limiting our ability to evaluate the interventions. Vidal et al. 62 reported an annual increase in migration percentage of 5.5% in a study of 158 children with CP who underwent an adductor tenotomy. In a population of children followed until orthopaedic hip surgery or most recent radiograph (up to age 9y 7mo), Terjesen 4 found a mean increase in migration percentage of 4% (À9% to 49%) per year. Further population-based studies of the natural rate of progression are required to further our understanding of the expected annual change in migration percentage. Hip surveillance programmes that follow children longitudinally from a young age provide this opportunity.
In the current body of literature, comparison of prevention strategies is impossible owing to the heterogeneity in patient populations within and across prevention categories. The rate of change of migration percentage and the risk of hip displacement differ according to GMFCS level.
1-4,62 Terjesen 4 reported an annual increase in migration percentage of 0.2% for children in GMFCS level I compared with 9.5% for those in level V. Despite this, most studies in this review (excluding those on positioning), included children in GMFCS levels I and II who were known to be at low risk for hip displacement. Given the significant difference in risk of progression, the impact of intervention should be studied based on GMFCS levels. Similarly, the rate of hip displacement has also been reported to be greatest at a young age, 4 although progression at an older age is difficult to assess as many children undergo orthopaedic surgery to halt further progression. Participants in the included studies ranged in age from 9 months (Pidcock et al. 36 ) to 31 years (Krach et al. 42 ). If risk is highest at a young age, interventions provided at that time may be most effective. Positioning, for example, may be the intervention most effectively leveraged to prevent or slow hip displacement as treatments such as supported standing can be safely started as early as 9 to 10 months of age. 67 However, we must recognize that some of the interventions studied (e.g. SDR) were not done with the intention of slowing or preventing hip displacement. Instead, patient selection, age at intervention, and timing of the intervention would have been based primarily on the child's function and goals.
Finally, the clinical relevance of prevention of hip displacement progression was poorly defined. A migration percentage change of greater than 10% has been reported to be clinically important; 16, 17, 19 however, when thinking about prevention strategies, it is probably more beneficial to the patient to prevent a change from 30% to 40% than it is to prevent a change from 75% to 85%. Consideration must, therefore, be given to the migration percentage at which an intervention is introduced. Studies in this systematic review included children and young people with initial migration percentages of 0% to 89%. It is unrealistic to expect a non-orthopaedic surgery intervention to correct a migration percentage greater than 60%. Additionally, clinical relevance requires that children be followed until skeletal maturity to effectively assess the impact of an intervention on hip displacement.
Limitations of the review
This systematic review had several limitations. Most studies included in it were of low quality with small, heterogeneous sample sizes. An effective systematic review requires a larger number of studies. There was no defined primary outcome that spanned all the articles, limiting our ability to compare results. Additionally, we lack a clear understanding of the annual rate of change in migration percentage in children with CP. Without an adequate control group, a priori determination of clinically significant changes in pertinent variables, and larger sample sizes, no definitive conclusions can be drawn on the impact of interventions to prevent hip displacement. This review focused on radiological measures to evaluate progressive hip displacement and, as such, only considered the body function and structure domain of the ICF. No studies in this review investigated the impact of progressive hip displacement on activity and participation.
Future considerations
This systematic review has emphasized the lack of evidence in the literature on prevention strategies for hip displacement in CP. Future studies should include annual rate of change in migration percentage as an outcome measure. Given the relatively small or neutral effects observed in many of the studies with low levels of evidence in this review, non-inferiority trials will be an important future direction. Such trials are designed to show that one treatment is no worse than another based on a predetermined margin. This design will allow a more definitive comparison between various interventions and with the natural progression of hip displacement. Patients must be stratified by several different factors including age, GMFCS level, and initial migration percentage to allow effectiveness comparisons between prevention strategies. Studies aiming to slow or prevent hip displacement should ideally start when migration percentage is below 30% to 40%. Longitudinal followup (ideally until skeletal maturity), is required to determine the clinical relevance of interventions. Consideration must be given to adjuvant interventions and therapies provided during the study period. Additional outcome measures investigating the impact of hip displacement and the interventions used to treat it, and on the ICF domains of activity and participation (such as quality of life), should also be included.
Conclusion
The overall level of evidence of the articles included in this review was poor. None of the interventions demonstrated a large treatment effect on hip displacement. No recommendations can be provided on interventions to slow or prevent hip displacement on the basis of the available evidence reviewed. This lack of evidence highlights the need for more strategic, controlled, prospective studies on hip displacement in children and young people with CP to fully understand the impact of different prevention strategies on their effectiveness and the patients' quality of life.
SUPPORTING INFORMATION
The following additional material may be found online: Figure S1 : Search results and exclusion of articles. 
